🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
6.70
+0.44 (7.03%)
At close: Nov 18, 2026, 4:00 PM EST
6.70
0.00 (0.00%)
Pre-market: Nov 19, 2026, 8:37 AM EST

ImmunityBio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
45.0888.33143.43265.45104.64181.1
Short-Term Investments
289.25154.486.381.012.54136.02
Cash & Short-Term Investments
334.33242.82149.81266.46107.18317.12
Cash Growth
29.68%62.09%-43.78%148.60%-66.20%230.12%
Accounts Receivable
53.642.572.36---
Other Receivables
0.010.050.293.171.891.33
Receivables
53.6142.622.653.171.891.33
Inventory
0.010.918.27-2.16-
Prepaid Expenses
30.8416.8516.7313.9814.7412.25
Other Current Assets
-11.687.1210.4714.63.65
Total Current Assets
418.79314.88184.59294.08140.58334.35
Property, Plant & Equipment
142.89147.55170.46182.68189.58119.17
Long-Term Investments
-14.210.70.890.847.6
Goodwill
-0.910.91---
Other Intangible Assets
10.7613.0415.0217.09201.42
Other Long-Term Assets
36.963.944.132.824.73-
Total Assets
609.39501.9382.93504.45362.36468.91

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
13.846.986.739.221.0211.42
Accrued Expenses
75.9542.0138.2839.5334.2333.94
Short-Term Debt
-1.751.251.48433.32301.83
Current Portion of Leases
7.377.597.475.312.733.01
Other Current Liabilities
0.933.421.222.779.5718.8
Total Current Liabilities
98.0961.7554.9458.28500.86369
Long-Term Debt
1,261801.71746.28836.95241.27306.35
Long-Term Leases
27.4533.6734.8239.9448.0237.07
Other Long-Term Liabilities
368.02104.3435.01155.2122.030.41
Total Liabilities
1,7551,001871.061,090812.18712.82

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.110.10.090.070.040.04
Additional Paid-In Capital
3,6013,1972,8852,3751,9311,720
Retained Earnings
-4,774-3,727-3,375-2,962-2,378-1,962
Comprehensive Income & Other
26.8828.961.20.010.180
Total Common Equity
-1,146-500.47-489.1-586.99-447.33-242.17
Minority Interest
0.850.90.971.05-2.49-1.74
Shareholders' Equity
-1,145-499.57-488.13-585.94-449.82-243.91
Total Liabilities & Equity
609.39501.9382.93504.45362.36468.91

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,296844.72789.82883.68725.33648.26
Net Cash (Debt)
-961.77-601.9-640.01-616.32-617.31-330.32
Net Cash Growth
------
Net Cash Per Share
-0.93-0.65-0.91-1.21-1.54-0.85
Filing Date Shares Outstanding
1,0641,028853.44673.95435.84397.91
Total Common Shares Outstanding
1,0641,012852.9670.87421.57397.83
Working Capital
320.7253.12129.64235.8-360.28-34.65
Book Value Per Share
-1.08-0.49-0.57-0.87-1.06-0.61
Tangible Book Value
-1,157-514.42-505.03-604.08-467.33-243.59
Tangible Book Value Per Share
-1.09-0.51-0.59-0.90-1.11-0.61
Machinery
-65.1375.4471.869.8555.34
Construction In Progress
-86.4386.4284.4472.6916.58
Leasehold Improvements
-73.1473.1372.5568.7162.48
SEC Filings: 10-K · 10-Q